KDM1A and breast cancer: Knockdown (KD) or inhibition of LSD1 reduces both the invasiveness and proliferative capacity of BC cells in vitro (19,20) and small molecules targeting LSD1 induce terminal differentiation of leukaemia cells (21,22).